Allstate Corporation’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.7M | Buy |
595,780
+177,142
| +42% | +$4.72M | 0.18% | 75 |
|
|
2025
Q4 | $10.4M | Buy |
418,638
+214,443
| +105% | +$5.41M | 0.14% | 99 |
|
|
2025
Q3 | $5.2M | Buy |
204,195
+195,335
| +2,205% | +$4.82M | 0.12% | 95 |
|
|
2025
Q2 | $215K | Sell |
8,860
-213,403
| -96% | -$4.98M | 0.02% | 166 |
|
|
2025
Q1 | $5.63M | Buy |
222,263
+54,287
| +32% | +$1.42M | 0.17% | 75 |
|
|
2024
Q4 | $4.46M | Buy |
+167,976
| New | +$4.56M | 0.13% | 84 |
|
|
2024
Q3 | – | Sell |
-15,872
| Closed | -$444K | – | 198 |
|
|
2024
Q2 | $444K | Buy |
15,872
+1,862
| +13% | +$51.3K | 0.04% | 129 |
|
|
2024
Q1 | $389K | Sell |
14,010
-6,033
| -30% | -$167K | 0.03% | 139 |
|
|
2023
Q4 | $577K | Buy |
20,043
+588
| +3% | +$17.8K | 0.04% | 95 |
|
|
2023
Q3 | $645K | Hold |
19,455
| – | – | 0.04% | 92 |
|
|
2023
Q2 | $714K | Sell |
19,455
-138
| -0.7% | -$5.37K | 0.05% | 90 |
|
|
2023
Q1 | $799K | Sell |
19,593
-209,176
| -91% | -$9.03M | 0.06% | 78 |
|
|
2022
Q4 | $11.7M | Buy |
228,769
+3,132
| +1% | +$150K | 0.36% | 41 |
|
|
2022
Q3 | $9.87M | Sell |
225,637
-1,064
| -0.5% | -$51.7K | 0.28% | 49 |
|
|
2022
Q2 | $11.9M | Sell |
226,701
-204,265
| -47% | -$10.4M | 0.37% | 40 |
|
|
2022
Q1 | $22.3M | Buy |
430,966
+23,533
| +6% | +$1.22M | 0.6% | 26 |
|
|
2021
Q4 | $24.1M | Buy |
407,433
+299,828
| +279% | +$14.9M | 0.46% | 33 |
|
|
2021
Q3 | $4.63M | Sell |
107,605
-7,822
| -7% | -$347K | 0.19% | 44 |
|
|
2021
Q2 | $4.52M | Sell |
115,427
-16,133
| -12% | -$627K | 0.15% | 53 |
|
|
2021
Q1 | $4.77M | Sell |
131,560
-1,149
| -0.9% | -$40.8K | 0.15% | 55 |
|
|
2020
Q4 | $4.88M | Sell |
132,709
-78
| -0.1% | -$2.86K | 0.15% | 48 |
|
|
2020
Q3 | $4.62M | Sell |
132,787
-22,537
| -15% | -$790K | 0.15% | 45 |
|
|
2020
Q2 | $4.82M | Sell |
155,324
-12,236
| -7% | -$416K | 0.17% | 49 |
|
|
2020
Q1 | $5.19M | Sell |
167,560
-243,925
| -59% | -$8.31M | 0.2% | 40 |
|
|
2019
Q4 | $15.3M | Sell |
411,485
-712
| -0.2% | -$25.4K | 0.28% | 37 |
|
|
2019
Q3 | $14.1M | Sell |
412,197
-166,221
| -29% | -$6.04M | 0.24% | 42 |
|
|
2019
Q2 | $23.8M | Buy |
578,418
+99,561
| +21% | +$3.95M | 0.42% | 27 |
|
|
2019
Q1 | $19.3M | Sell |
478,857
-2,750
| -0.6% | -$110K | 0.52% | 26 |
|
|
2018
Q4 | $19.9M | Buy |
481,607
+473,837
| +6,098% | +$19.7M | 0.66% | 21 |
|
|
2018
Q3 | $325K | Sell |
7,770
-293
| -4% | -$11.3K | 0.02% | 25 |
|
|
2018
Q2 | $278K | Buy |
8,063
+1,960
| +32% | +$67K | 0.01% | 26 |
|
|
2018
Q1 | $205K | Buy |
6,103
+47
| +0.8% | +$1.62K | 0.01% | 25 |
|
|
2017
Q4 | $208K | Buy |
+6,056
| New | +$206K | 0.01% | 25 |
|
|
2017
Q3 | – | Sell |
-172,848
| Closed | -$5.51M | – | 194 |
|
|
2017
Q2 | $5.51M | Sell |
172,848
-17,342
| -9% | -$547K | 0.29% | 20 |
|
|
2017
Q1 | $6.17M | Sell |
190,190
-148,702
| -44% | -$4.69M | 0.37% | 27 |
|
|
2016
Q4 | $10.4M | Buy |
338,892
+12,636
| +4% | +$386K | 0.62% | 39 |
|
|
2016
Q3 | $10.5M | Sell |
326,256
-57,479
| -15% | -$1.92M | 0.74% | 18 |
|
|
2016
Q2 | $12.8M | Buy |
383,735
+99,765
| +35% | +$3.18M | 0.84% | 19 |
|
|
2016
Q1 | $7.99M | Sell |
283,970
-168,580
| -37% | -$4.82M | 0.69% | 45 |
|
|
2015
Q4 | $13.9M | Buy |
452,550
+328,765
| +266% | +$10.3M | 1.32% | 16 |
|
|
2015
Q3 | $3.69M | Sell |
123,785
-2,688
| -2% | -$86.2K | 0.38% | 62 |
|
|
2015
Q2 | $4.02M | Sell |
126,473
-457,379
| -78% | -$14.9M | 0.36% | 70 |
|
|
2015
Q1 | $19.3M | Buy |
583,852
+17,850
| +3% | +$567K | 1.61% | 7 |
|
|
2014
Q4 | $16.7M | Buy |
566,002
+413,091
| +270% | +$11.8M | 1.28% | 12 |
|
|
2014
Q3 | $4.29M | Buy |
+152,911
| New | +$4.29M | 0.2% | 173 |
|
Other funds holding PFE
VCM
VPM
Allstate Corporation's PFE Position: Q1 2026 in Review
Allstate Corporation increased its Pfizer (PFE) stake by 42% in Q1 2026, buying an estimated $4.72M and bringing the position to 595,780 shares worth $16.7M. The position accounts for 0.18% of the portfolio, ranked #75.
Allstate Corporation first reported a position in PFE in Q3 2014 and has held it in 45 quarters since. The position peaked at $24.1M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Allstate Corporation held 595,780 shares of Pfizer worth $16.7M as of Q1 2026.
- Allstate Corporation bought 177,142 Pfizer shares in Q1 2026, an estimated $4.72M.
- Pfizer made up 0.18% of Allstate Corporation's portfolio in Q1 2026, its #75 holding.
- Allstate Corporation first reported a position in Pfizer in Q3 2014 and has held it in 45 quarters since.
- Allstate Corporation's Pfizer position peaked at $24.1M in Q4 2021.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.